Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma
Ryota Kurimoto(Chiba University), Yuichi Takiguchi(Sanno Medical Center)
Cited by 39
Related Papers
Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site
|Journal of Clinical Oncology|2019|168
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site
|JAMA Oncology|2020|119
The mechanosensitive ion channel PIEZO1 is expressed in tendons and regulates physical performance
|Science Translational Medicine|2022|76